DexCom D&A increased by 2.9% to $67.10M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 11.8%, from $60.00M to $67.10M. Over 4 years (FY 2021 to FY 2025), D&A shows an upward trend with a 25.3% CAGR.
Higher levels indicate significant capital investment in infrastructure or acquisitions, while lower levels may suggest aging assets or limited capital expenditure.
This represents the non-cash expense allocated to the cost of tangible and intangible assets over their useful lives. Be...
High in capital-intensive industries like manufacturing and healthcare devices; lower in service-based sectors.
depreciation_and_amortization_cf| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $23.50M | $25.50M | $32.10M | $36.80M | $43.60M | $39.20M | $36.30M | $41.60M | $43.70M | $48.20M | $52.50M | $52.50M | $52.10M | $55.30M | $57.80M | $60.00M | $63.00M | $63.60M | $65.20M | $67.10M |
| QoQ Change | — | +8.5% | +25.9% | +14.6% | +18.5% | -10.1% | -7.4% | +14.6% | +5.0% | +10.3% | +8.9% | +0.0% | -0.8% | +6.1% | +4.5% | +3.8% | +5.0% | +1.0% | +2.5% | +2.9% |
| YoY Change | — | — | — | — | +85.5% | +53.7% | +13.1% | +13.0% | +0.2% | +23.0% | +44.6% | +26.2% | +19.2% | +14.7% | +10.1% | +14.3% | +20.9% | +15.0% | +12.8% | +11.8% |